Polunovsky (23 résultats)

Affiner la recherche

  • Livres (23)

à

Fourchette de prix personnalisée (EUR)

à

  • Langue : anglais

    Edité par Humana, 2010

    1603272704 / 9781603272704

    Série : Livre 64 sur 96 - Cancer Drug Discovery and Development

    • Couverture rigide

    Vendeur : Brook Bookstore On Demand, Napoli, NA, ItalieBrook Bookstore On Demand

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 81,64

    EUR 6,80 expédition 
    Expédition depuis Italie vers Etats-Unis

    Quantité disponible : 1 disponible(s)

    Etat : new.

  • Langue : anglais

    Edité par Humana, 2010

    1603272704 / 9781603272704

    Série : Livre 64 sur 96 - Cancer Drug Discovery and Development

    • Couverture rigide

    Vendeur : Ria Christie Collections, Uxbridge, Royaume-UniRia Christie Collections

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 227,13

    EUR 13,17 expédition 
    Expédition depuis Royaume-Uni vers Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Etat : New. In English.

  • Langue : anglais

    Edité par Humana, 2012

    1617796948 / 9781617796944

    Série : Livre 64 sur 96 - Cancer Drug Discovery and Development

    • Couverture souple

    Vendeur : Ria Christie Collections, Uxbridge, Royaume-UniRia Christie Collections

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 227,13

    EUR 13,17 expédition 
    Expédition depuis Royaume-Uni vers Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Etat : New. In English.

  • Autres images

    Langue : anglais

    Edité par Humana, 2012

    1617796948 / 9781617796944

    Série : Livre 64 sur 96 - Cancer Drug Discovery and Development

    • Couverture souple

    Vendeur : preigu, Osnabrück, Allemagnepreigu

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 184,95

    EUR 70,00 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 5 disponible(s)

    Taschenbuch. Etat : Neu. mTOR Pathway and mTOR Inhibitors in Cancer Therapy | Vitaly A. Polunovsky (u. a.) | Taschenbuch | Cancer Drug Discovery and Development | xii | Englisch | 2012 | Humana | EAN 9781617796944 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

  • Langue : anglais

    Edité par Humana Press Inc., 2012

    1617796948 / 9781617796944

    Série : Livre 64 sur 96 - Cancer Drug Discovery and Development

    • Couverture souple

    Vendeur : Kennys Bookshop and Art Galleries Ltd., Galway, GY, IrlandeKennys Bookshop and Art Galleries Ltd.

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 251,96

    EUR 9,50 expédition 
    Expédition depuis Irlande vers Etats-Unis

    Quantité disponible : 15 disponible(s)

    Etat : New. Editor(s): Polunovsky, V. A.; Houghton, Peter J. Series: Cancer Drug Discovery and Development. Num Pages: 304 pages, 3 colour tables, biography. BIC Classification: MJCL; MMG; PSF. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 17. Weight in Grams: 486. . 2012. Paperback. . . . .

  • Langue : anglais

    Edité par Humana Press Inc., 2010

    1603272704 / 9781603272704

    Série : Livre 64 sur 96 - Cancer Drug Discovery and Development

    • Couverture rigide

    Vendeur : Kennys Bookshop and Art Galleries Ltd., Galway, GY, IrlandeKennys Bookshop and Art Galleries Ltd.

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 253,22

    EUR 9,50 expédition 
    Expédition depuis Irlande vers Etats-Unis

    Quantité disponible : 15 disponible(s)

    Etat : New. Editor(s): Polunovsky, V. A.; Houghton, Peter J. Series: Cancer Drug Discovery and Development. Num Pages: 304 pages, 3 colour tables, biography. BIC Classification: MJCL. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 23. Weight in Grams: 695. . 2010. Hardback. . . . .

  • Langue : anglais

    Edité par Humana Press, 2010

    1603272704 / 9781603272704

    Série : Livre 64 sur 96 - Cancer Drug Discovery and Development

    • Couverture rigide

    Vendeur : Buchpark, Trebbin, AllemagneBuchpark

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Occasion - Très bon

    EUR 158,31

    EUR 105,00 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 1 disponible(s)

    Etat : Sehr gut. Zustand: Sehr gut | Seiten: 316 | Sprache: Englisch | Produktart: Bücher | The main objective of this book is to provide an up-to-date survey of the rapidly advancing eld of cancer therapy. Moreover, since our knowledge in this area rapidly evolves, some data have got obsolete during the process of book editing. Our understanding of the mechanisms involved in cancer genesis and progression underwent unprecedented expansion during the last decade, opening a new era of cancer treatment ¿ targeted therapy. The surge in this area results in no small part from studies conducted jointly by basic health scientists and clinical investigators. It is our hope that this book will help foster even further collaboration between investigators in these two disciplines. The target of rapamycin (TOR) was rst identi ed in Saccharomyces cerevisiae and subsequently in mammals (mTOR) as a conserved atypical serine/threonine kinase. In mammalian cells, mTOR exists in at least two multi-protein complexes that have critical roles in regulating cellular homeostasis and survival. As with many other areas of science, discovery of TOR signaling was fortuitous. Rapamycin was isolated as a product of the soil bacteria Streptomyces hygroscopicus, identi ed in a soil sample taken from the island of Rapa Nui (Easter Island). Rapamycin was rst discovered to be a potent antifungal agent and next as an immune suppressive drug. It was only later that it was found to be active as an antitumor agent in non-clinical models; although it was not developed for this indication. The history of rapamycin presents one of the rst examples of chemical genetics.

  • Langue : anglais

    Edité par Humana Press, 2012

    1617796948 / 9781617796944

    Série : Livre 64 sur 96 - Cancer Drug Discovery and Development

    • Couverture souple

    Vendeur : Revaluation Books, Exeter, Royaume-UniRevaluation Books

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 304,59

    EUR 11,66 expédition 
    Expédition depuis Royaume-Uni vers Etats-Unis

    Quantité disponible : 2 disponible(s)

    Paperback. Etat : Brand New. 316 pages. 9.25x6.10x0.75 inches. In Stock.

  • Langue : anglais

    Edité par Humana Pr Inc, 2010

    1603272704 / 9781603272704

    Série : Livre 64 sur 96 - Cancer Drug Discovery and Development

    • Couverture rigide

    Vendeur : Revaluation Books, Exeter, Royaume-UniRevaluation Books

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 306,03

    EUR 14,58 expédition 
    Expédition depuis Royaume-Uni vers Etats-Unis

    Quantité disponible : 2 disponible(s)

    Hardcover. Etat : Brand New. 1st edition. 301 pages. 9.25x6.25x1.00 inches. In Stock.

  • Langue : anglais

    Edité par Humana Press Inc., 2012

    1617796948 / 9781617796944

    Série : Livre 64 sur 96 - Cancer Drug Discovery and Development

    • Couverture souple

    Vendeur : Kennys Bookstore, Olney, MD, Etats-UnisKennys Bookstore

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 318,50

    EUR 9,15 expédition 
    Expédition nationale : Etats-Unis

    Quantité disponible : 15 disponible(s)

    Etat : New. Editor(s): Polunovsky, V. A.; Houghton, Peter J. Series: Cancer Drug Discovery and Development. Num Pages: 304 pages, 3 colour tables, biography. BIC Classification: MJCL; MMG; PSF. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 17. Weight in Grams: 486. . 2012. Paperback. . . . . Books ship from the US and Ireland.

  • Langue : anglais

    Edité par Humana Press Inc., 2010

    1603272704 / 9781603272704

    Série : Livre 64 sur 96 - Cancer Drug Discovery and Development

    • Couverture rigide

    Vendeur : Kennys Bookstore, Olney, MD, Etats-UnisKennys Bookstore

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 320,09

    EUR 9,15 expédition 
    Expédition nationale : Etats-Unis

    Quantité disponible : 15 disponible(s)

    Etat : New. Editor(s): Polunovsky, V. A.; Houghton, Peter J. Series: Cancer Drug Discovery and Development. Num Pages: 304 pages, 3 colour tables, biography. BIC Classification: MJCL. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 23. Weight in Grams: 695. . 2010. Hardback. . . . . Books ship from the US and Ireland.

  • Langue : anglais

    Edité par Humana, 2010

    1603272704 / 9781603272704

    Série : Livre 64 sur 96 - Cancer Drug Discovery and Development

    • Couverture rigide

    Vendeur : Mispah books, Redhill, SURRE, Royaume-UniMispah books

    Vendeur avec une évaluation de 4 étoiles
    Contacter le vendeur

    Etat: Occasion - Comme neuf

    EUR 334,01

    EUR 29,16 expédition 
    Expédition depuis Royaume-Uni vers Etats-Unis

    Quantité disponible : 1 disponible(s)

    Hardcover. Etat : Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

  • Etat: Occasion - Satisfaisant

    EUR 178,57

    EUR 8,70 expédition 
    Expédition nationale : Etats-Unis

    Quantité disponible : 1 disponible(s)

    Ajouter au panier

    Hardcover. Etat : Good. In Russian. Polunovsky, Albert Grigorievich. Construction of vertical drainage piles in the construction of highways on weak ground. Moscow: 1974. All images are for identification of editions only. Several books of the same edition may be available. Please feel free to request photos of available books.SKU7329055.

  • Langue : anglais

    Edité par Humana, 2012

    1617796948 / 9781617796944

    Série : Livre 64 sur 96 - Cancer Drug Discovery and Development

    • Couverture souple
    • impression à la demande

    Vendeur : Brook Bookstore On Demand, Napoli, NA, ItalieBrook Bookstore On Demand

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 166,29

    EUR 5,50 expédition 
    Expédition depuis Italie vers Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Etat : new. Questo è un articolo print on demand.

  • Langue : anglais

    Edité par Humana, 2010

    1603272704 / 9781603272704

    Série : Livre 64 sur 96 - Cancer Drug Discovery and Development

    • Couverture rigide
    • impression à la demande

    Vendeur : Brook Bookstore On Demand, Napoli, NA, ItalieBrook Bookstore On Demand

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 166,29

    EUR 6,80 expédition 
    Expédition depuis Italie vers Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Etat : new. Questo è un articolo print on demand.

  • Langue : anglais

    Edité par Humana Press, 2012

    1617796948 / 9781617796944

    Série : Livre 64 sur 96 - Cancer Drug Discovery and Development

    • Couverture souple
    • impression à la demande

    Vendeur : moluna, Greven, Allemagnemoluna

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 180,07

    EUR 48,99 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. The main objective of this book is to provide an up-to-date survey of the rapidly advancing eld of cancer therapy. Moreover, since our knowledge in this area rapidly evolves, some data have got obsolete during the process of book editing. Our understanding .

  • Langue : anglais

    Edité par Humana Press, 2010

    1603272704 / 9781603272704

    Série : Livre 64 sur 96 - Cancer Drug Discovery and Development

    • Couverture rigide
    • impression à la demande

    Vendeur : moluna, Greven, Allemagnemoluna

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 180,07

    EUR 48,99 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. The main objective of this book is to provide an up-to-date survey of the rapidly advancing eld of cancer therapy. Moreover, since our knowledge in this area rapidly evolves, some data have got obsolete during the process of book editing. Our understanding .

  • Langue : anglais

    Edité par Humana Press Okt 2012, 2012

    1617796948 / 9781617796944

    Série : Livre 64 sur 96 - Cancer Drug Discovery and Development

    • Couverture souple
    • impression à la demande

    Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, AllemagneBuchWeltWeit Ludwig Meier e.K.

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 213,99

    EUR 23,00 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 2 disponible(s)

    Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The main objective of this book is to provide an up-to-date survey of the rapidly advancing eld of cancer therapy. Moreover, since our knowledge in this area rapidly evolves, some data have got obsolete during the process of book editing. Our understanding of the mechanisms involved in cancer genesis and progression underwent unprecedented expansion during the last decade, opening a new era of cancer treatment - targeted therapy. The surge in this area results in no small part from studies conducted jointly by basic health scientists and clinical investigators. It is our hope that this book will help foster even further collaboration between investigators in these two disciplines. The target of rapamycin (TOR) was rst identi ed in Saccharomyces cerevisiae and subsequently in mammals (mTOR) as a conserved atypical serine/threonine kinase. In mammalian cells, mTOR exists in at least two multi-protein complexes that have critical roles in regulating cellular homeostasis and survival. As with many other areas of science, discovery of TOR signaling was fortuitous. Rapamycin was isolated as a product of the soil bacteria Streptomyces hygroscopicus, identi ed in a soil sample taken from the island of Rapa Nui (Easter Island). Rapamycin was rst discovered to be a potent antifungal agent and next as an immune suppressive drug. It was only later that it was found to be active as an antitumor agent in non-clinical models; although it was not developed for this indication. The history of rapamycin presents one of the rst examples of chemical genetics. 316 pp. Englisch.

  • Langue : anglais

    Edité par Humana Press Aug 2010, 2010

    1603272704 / 9781603272704

    Série : Livre 64 sur 96 - Cancer Drug Discovery and Development

    • Couverture rigide
    • impression à la demande

    Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, AllemagneBuchWeltWeit Ludwig Meier e.K.

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 213,99

    EUR 23,00 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 2 disponible(s)

    Buch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The main objective of this book is to provide an up-to-date survey of the rapidly advancing eld of cancer therapy. Moreover, since our knowledge in this area rapidly evolves, some data have got obsolete during the process of book editing. Our understanding of the mechanisms involved in cancer genesis and progression underwent unprecedented expansion during the last decade, opening a new era of cancer treatment - targeted therapy. The surge in this area results in no small part from studies conducted jointly by basic health scientists and clinical investigators. It is our hope that this book will help foster even further collaboration between investigators in these two disciplines. The target of rapamycin (TOR) was rst identi ed in Saccharomyces cerevisiae and subsequently in mammals (mTOR) as a conserved atypical serine/threonine kinase. In mammalian cells, mTOR exists in at least two multi-protein complexes that have critical roles in regulating cellular homeostasis and survival. As with many other areas of science, discovery of TOR signaling was fortuitous. Rapamycin was isolated as a product of the soil bacteria Streptomyces hygroscopicus, identi ed in a soil sample taken from the island of Rapa Nui (Easter Island). Rapamycin was rst discovered to be a potent antifungal agent and next as an immune suppressive drug. It was only later that it was found to be active as an antitumor agent in non-clinical models; although it was not developed for this indication. The history of rapamycin presents one of the rst examples of chemical genetics. 316 pp. Englisch.

  • Langue : anglais

    Edité par Humana Press, Humana Aug 2010, 2010

    1603272704 / 9781603272704

    Série : Livre 64 sur 96 - Cancer Drug Discovery and Development

    • Couverture rigide
    • impression à la demande

    Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagnebuchversandmimpf2000

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 213,99

    EUR 60,00 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 1 disponible(s)

    Buch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -The main objective of this book is to provide an up-to-date survey of the rapidly advancing eld of cancer therapy. Moreover, since our knowledge in this area rapidly evolves, some data have got obsolete during the process of book editing. Our understanding of the mechanisms involved in cancer genesis and progression underwent unprecedented expansion during the last decade, opening a new era of cancer treatment ¿ targeted therapy. The surge in this area results in no small part from studies conducted jointly by basic health scientists and clinical investigators. It is our hope that this book will help foster even further collaboration between investigators in these two disciplines. The target of rapamycin (TOR) was rst identi ed in Saccharomyces cerevisiae and subsequently in mammals (mTOR) as a conserved atypical serine/threonine kinase. In mammalian cells, mTOR exists in at least two multi-protein complexes that have critical roles in regulating cellular homeostasis and survival. As with many other areas of science, discovery of TOR signaling was fortuitous. Rapamycin was isolated as a product of the soil bacteria Streptomyces hygroscopicus, identi ed in a soil sample taken from the island of Rapa Nui (Easter Island). Rapamycin was rst discovered to be a potent antifungal agent and next as an immune suppressive drug. It was only later that it was found to be active as an antitumor agent in non-clinical models; although it was not developed for this indication. The history of rapamycin presents one of the rst examples of chemical genetics.Springer-Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 316 pp. Englisch.

  • Langue : anglais

    Edité par Humana Press, Humana Press Okt 2012, 2012

    1617796948 / 9781617796944

    Série : Livre 64 sur 96 - Cancer Drug Discovery and Development

    • Couverture souple
    • impression à la demande

    Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagnebuchversandmimpf2000

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 213,99

    EUR 60,00 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 1 disponible(s)

    Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -The main objective of this book is to provide an up-to-date survey of the rapidly advancing eld of cancer therapy. Moreover, since our knowledge in this area rapidly evolves, some data have got obsolete during the process of book editing. Our understanding of the mechanisms involved in cancer genesis and progression underwent unprecedented expansion during the last decade, opening a new era of cancer treatment ¿ targeted therapy. The surge in this area results in no small part from studies conducted jointly by basic health scientists and clinical investigators. It is our hope that this book will help foster even further collaboration between investigators in these two disciplines. The target of rapamycin (TOR) was rst identi ed in Saccharomyces cerevisiae and subsequently in mammals (mTOR) as a conserved atypical serine/threonine kinase. In mammalian cells, mTOR exists in at least two multi-protein complexes that have critical roles in regulating cellular homeostasis and survival. As with many other areas of science, discovery of TOR signaling was fortuitous. Rapamycin was isolated as a product of the soil bacteria Streptomyces hygroscopicus, identi ed in a soil sample taken from the island of Rapa Nui (Easter Island). Rapamycin was rst discovered to be a potent antifungal agent and next as an immune suppressive drug. It was only later that it was found to be active as an antitumor agent in non-clinical models; although it was not developed for this indication. The history of rapamycin presents one of the rst examples of chemical genetics.Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin 316 pp. Englisch.

  • Langue : anglais

    Edité par Humana, 2012

    1617796948 / 9781617796944

    Série : Livre 64 sur 96 - Cancer Drug Discovery and Development

    • Couverture souple
    • impression à la demande

    Vendeur : AHA-BUCH GmbH, Einbeck, AllemagneAHA-BUCH GmbH

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 297,68

    EUR 30,50 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 1 disponible(s)

    Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The main objective of this book is to provide an up-to-date survey of the rapidly advancing eld of cancer therapy. Moreover, since our knowledge in this area rapidly evolves, some data have got obsolete during the process of book editing. Our understanding of the mechanisms involved in cancer genesis and progression underwent unprecedented expansion during the last decade, opening a new era of cancer treatment - targeted therapy. The surge in this area results in no small part from studies conducted jointly by basic health scientists and clinical investigators. It is our hope that this book will help foster even further collaboration between investigators in these two disciplines. The target of rapamycin (TOR) was rst identi ed in Saccharomyces cerevisiae and subsequently in mammals (mTOR) as a conserved atypical serine/threonine kinase. In mammalian cells, mTOR exists in at least two multi-protein complexes that have critical roles in regulating cellular homeostasis and survival. As with many other areas of science, discovery of TOR signaling was fortuitous. Rapamycin was isolated as a product of the soil bacteria Streptomyces hygroscopicus, identi ed in a soil sample taken from the island of Rapa Nui (Easter Island). Rapamycin was rst discovered to be a potent antifungal agent and next as an immune suppressive drug. It was only later that it was found to be active as an antitumor agent in non-clinical models; although it was not developed for this indication. The history of rapamycin presents one of the rst examples of chemical genetics.

  • Langue : anglais

    Edité par Humana, 2010

    1603272704 / 9781603272704

    Série : Livre 64 sur 96 - Cancer Drug Discovery and Development

    • Couverture rigide
    • impression à la demande

    Vendeur : AHA-BUCH GmbH, Einbeck, AllemagneAHA-BUCH GmbH

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 297,68

    EUR 30,50 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 1 disponible(s)

    Buch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The main objective of this book is to provide an up-to-date survey of the rapidly advancing eld of cancer therapy. Moreover, since our knowledge in this area rapidly evolves, some data have got obsolete during the process of book editing. Our understanding of the mechanisms involved in cancer genesis and progression underwent unprecedented expansion during the last decade, opening a new era of cancer treatment - targeted therapy. The surge in this area results in no small part from studies conducted jointly by basic health scientists and clinical investigators. It is our hope that this book will help foster even further collaboration between investigators in these two disciplines. The target of rapamycin (TOR) was rst identi ed in Saccharomyces cerevisiae and subsequently in mammals (mTOR) as a conserved atypical serine/threonine kinase. In mammalian cells, mTOR exists in at least two multi-protein complexes that have critical roles in regulating cellular homeostasis and survival. As with many other areas of science, discovery of TOR signaling was fortuitous. Rapamycin was isolated as a product of the soil bacteria Streptomyces hygroscopicus, identi ed in a soil sample taken from the island of Rapa Nui (Easter Island). Rapamycin was rst discovered to be a potent antifungal agent and next as an immune suppressive drug. It was only later that it was found to be active as an antitumor agent in non-clinical models; although it was not developed for this indication. The history of rapamycin presents one of the rst examples of chemical genetics.